Evidence map›Paper›PMID 39134398›Full record

ArticleSexually transmitted infections2025

Sexually transmitted infections and migration in Uganda: a population-based study.

Michelle A Moffa, Xinyi Feng, Josephine Mpagazi, Stephen Kiboneka, Robert Ssekubugu, John Baptiste Kereba, Annet Nakayijja, Julius Tukundane, Jade Jackson, Caitlin E Kennedy and 11 more

Abstract read
In one paragraph

Article in Sexually transmitted infections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Michelle A MoffaThe Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-2830-946X
Xinyi FengDepartment of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Josephine MpagaziRakai Health Sciences Program, Kalisizo, Central Region, Uganda.
Stephen KibonekaRakai Health Sciences Program, Kalisizo, Central Region, Uganda.
Robert SsekubuguRakai Health Sciences Program, Kalisizo, Central Region, Uganda.
John Baptiste KerebaRakai Health Sciences Program, Kalisizo, Central Region, Uganda.
Annet NakayijjaRakai Health Sciences Program, Kalisizo, Central Region, Uganda.
Julius TukundaneRakai Health Sciences Program, Kalisizo, Central Region, Uganda.
Jade JacksonDepartment of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Caitlin E KennedyInternational Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0001-6820-063X
Godfrey KigoziRakai Health Sciences Program, Kalisizo, Central Region, Uganda.
Ronald M GaliwangoRakai Health Sciences Program, Kalisizo, Central Region, Uganda.ORCID 0000-0003-3702-5722
Yukari C ManabeDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Charlotte A GaydosDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-1021-3195
Larry W ChangDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Sarah KalibalaRakai Health Sciences Program, Kalisizo, Central Region, Uganda.
Steven J ReynoldsDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Aaron Ar TobianDepartment of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Thomas QuinnDepartment of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
M Kate Grabowski *Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA mgrabow2@jhu.edu.
Joseph Kagayi *Rakai Health Sciences Program, Kalisizo, Central Region, Uganda.

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Structural and Social Transitions Among Adolescents in Rakai (SSTAR)R01HD091003 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SANTELLI, JOHN S. · 2017 to 2021
$3.7M
RCT to reduce HIV acquisition and viral load among migrants, Rakai, UgandaR01MH115799 · NIMH · JOHNS HOPKINS UNIVERSITY · PI CHANG, LARRY WILLIAM, WAWER, MARIA J · 2018 to 2022
$2.9M
CHWs, mHealth, and Combination HIV Prevention in a Hotspot: A Randomized TrialR01MH107275 · NIMH · JOHNS HOPKINS UNIVERSITY · PI CHANG, LARRY WILLIAM · 2015 to 2019
$2.7M
Long-term impact of universal treatment and dolutegravir on population HIV virologic and incidence outcomes in Africa: The LONGVIEW StudyR01AI155080 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GRABOWSKI, MARY KATHRYN · 2021 to 2024
$2.5M
Hard-to-Reach Populations: Implications for Ending the AIDS EpidemicR01AI143333 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CHANG, LARRY WILLIAM · 2019 to 2022
$2.4M
Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic Control through PrEP: The IN-STEP studyR01AI177132 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Mary Kathryn Grabowski · 2024 to 2026
$1.9M
Revealing women's hidden role as critical components of HIV transmission networks in Rakai, Uganda: an interdisciplinary approachK01AI125086 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GRABOWSKI, MARY KATHRYN · 2016 to 2020
$638k
NIAID NIH HHS K01 AI125086NIAID NIH HHS P30 AI094189NIAID NIH HHS R01 AI143333NIAID NIH HHS R01 AI155080NIAID NIH HHS R01 AI177132NICHD NIH HHS R01 HD091003NIMH NIH HHS R01 MH107275NIMH NIH HHS R01 MH115799
6 · The paper itself

Abstract

objectivesMigration is associated with increased risk of HIV infection in Africa, but evidence about non-HIV sexually transmitted infection (STI) burden among African migrants is limited.

methodsWe used data from the Sexually Transmitted Infection Prevalence Study, a cross-sectional population-based study of chlamydia, gonorrhoea, trichomoniasis, syphilis and herpes simplex virus type 2 prevalence in southern Uganda, to compare STI prevalence between adults aged 18 and 49 years with and without a recent history of migration. Migration status was determined using household census data, with a recent migration history defined as having moved into one's community of current residence within the last ~18 months. Unadjusted and adjusted modified Poisson regression models were used to compare individual STI prevalence risk by recent migration status with associations reported as adjusted prevalence risk ratios (adjPRRs) with 95% CIs. Adjusted models included participants' sex, age, community type, education, occupation and marital status.

resultsAmong 1825 participants, 358 (19.6%) had a recent migration history. Overall, migrants exhibited a significantly higher combined prevalence of curable STIs (gonorrhoea, chlamydia, high-titre syphilis (rapid plasma regain ≥1:8) and trichomoniasis) as compared with long-term residents (34.4% vs 24.2%; adjPRR=1.23; 95% CI 1.03 to 1.47). Significant differences in curable STI prevalence by migration status were concentrated among persons living with HIV (49.4% prevalence in migrants vs 32.6% in long-term residents; adjPRR=1.42; 95% CI 1.10 to 1.85) and among women (38.8% in migrants vs 27.8% in long-term residents; adjPRR=1.26; 95% CI 1.01 to 1.58). High-titre syphilis prevalence was especially elevated among male migrants (11.2% in migrants vs 4.9% in long-term residents; adjPRR=1.82; 95% CI 1.06 to 3.13).

conclusionsThe prevalence of non-HIV STIs is higher among migrants. Tailored outreach and service delivery approaches that address the needs of mobile populations are crucial for integrated HIV and STI epidemic control in Uganda to optimise resources and reduce transmission risks.

Indexed as

Sexually Transmitted DiseasesTransients and MigrantsAdolescentAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedPrevalenceRisk FactorsSyphilisUgandaYoung AdultAFRICAHIVMIGRATIONSYPHILIS

Identifiers

PMID39134398
PMCPMC12952536

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.